Ticker Symbol: MGTA
Magenta Therapeutics Inc
$7.22 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001690585
Company Profile
Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of immune system reset through stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: 100 Technology Sq Fl 5
Website: www.magentatx.com
CEO: Jason Gardner
Tags:
- Health Technology
- Biotechnology
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: $0.68 - $0.75
Beta: -
52wk. High: $2.24
52wk. Low: $0.32
Ytd. Change 77.11%
50 Day Moving Average: $0.67
200 Day Moving Average: $0.70
Shares Outstanding: 60648883
Valuation
Market Cap: 4.2B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A